Bone Metabolism Parameters in Patients Undergoing Intravenous Calcitriol Treatment

  • D. Rolla
  • D. Lamperi
  • E. Paoletti
  • G. Molinelli
  • C. Augeri
  • R. De Grandi
  • P. L. Spirandelli
Chapter
Part of the Developments in Nephrology book series (DINE, volume 30)

Abstract

Intravenous calcitriol can be considered as the best pharmacological approach to secondary iperPTH. The aim of this study was to assess the effect of I.V. calcitriol (0,015 μcg/Kgbw) on some parameters of bone metabolism in 12 patients on RDT with moderate iperPTH. In front of a marked and significative soppression of PTH (Δ=-64%;p<0,0001) and a mild decrease of A.P. (p<0,001), bone Gla protein did not show any significant change. Furthemore, bone mineral content values (measured at the distal third of the forearm) showed a mild decrease in 4 patients. Therefore, it is possible that 1,250H2D3 at high doses decreases the trabecular mass.

Keywords

Dial Osteocalcin Triol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Silver J., Russel J., Sherwood L.M. Proc. Natl. Acad. Sci. USA 82: 4270–4273. 1985PubMedCrossRefGoogle Scholar
  2. 2).
    Dunlay R., Rodriguez M., Felsenfeld A.J., Llach F. Kid. Int. 36: 1093–1098, 1989CrossRefGoogle Scholar
  3. 3).
    Delmez J.A., Tindira C, Grooms P., Dusso A., Windus D.W., Slato-polsky E. J. Clin. Inv. 83: 1349–1355, 1989CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1991

Authors and Affiliations

  • D. Rolla
    • 1
  • D. Lamperi
    • 1
  • E. Paoletti
    • 1
  • G. Molinelli
    • 1
  • C. Augeri
    • 2
  • R. De Grandi
    • 2
  • P. L. Spirandelli
    • 2
  1. 1.Nephrology DivisionSt. Martin HospitalGenoaItaly
  2. 2.Nephrology Division and Laboratory DepartmentSt. Martin HospitalGenoaItaly

Personalised recommendations